newsfilter
← Latest News
GlobeNewswire·

Arcutis to Report Second Quarter 2026 Financial Results and Host Conference Call on August 5, 2026

WESTLAKE VILLAGE, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology,